The crucial drugs can have unintended consequences. Innovative therapies could shield the microbiome from their effects.

CVS appears uniquely positioned to improve health outcomes, and we appreciate management's focus on better leveraging its assets through digital and other means to bring a more consumer-centric ...

Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...

Overseeing this from a financial standpoint was James Rohrbaugh, who was hired as Northern Light Health's executive vice president and CFO in July 2024. Rohrbaugh says the system has made a ...

When our probation officers can perform at their best, they serve as counselors and mentors to actually prevent future crime ...

On this episode of "What's Health," host Dr. Joe Sirven highlights medical barriers faced by immigrants in the country ...

A United States District Court (N.D. California) ( “Court”) addressed in a February 3rd Order an issue arising out of the Occupational Safety ...

Key findings from a report titled "The Case for Change" have identified four drivers of some of the most pressing challenges facing health care in New York state. In this conversation, Bea Grause, R.N ...

The U.S. National Institutes of Health is lowering the maximum “indirect cost rate” that research institutions can charge the ...

But now DEI is under scrutiny for both public and private organizations. President Donald Trump signed an executive order Jan. 20 to remove DEI from the federal government. Large companies are ...

Smart watches, rings, and a growing array of patches are adding more functionality and being used across a growing set of applications.

Biosimilars have the potential to reduce health care costs and expand patient access, but economic and policy barriers affect adoption, explored James D. Chambers, PhD, MPharm, MSc, associate ...